Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Characterization of the Mechanistic Linkages Between Iodothyronine Deiodinase Inhibition and Impaired Thyroid-Mediated Growth and Development in Xenopus laevis Using Iopanoic Acid.
Haselman JT
,
Olker JH
,
Kosian PA
,
Korte JJ
,
Denny JS
,
Tietge JE
,
Hornung MW
,
Degitz SJ
.
???displayArticle.abstract???
Iodothyronine deiodinases (DIO) are key enzymes that influence tissue-specific thyroid hormone levels during thyroid-mediated amphibian metamorphosis. Within the larger context of evaluating chemicals for thyroid system disrupting potential, chemical activity toward DIOs is being evaluated using high-throughput in vitro screening assays as part of U.S. EPA's ToxCast program. However, existing data gaps preclude any inferences between in vitro chemical inhibition of DIOs and in vivo outcomes relevant to ecological risk assessment. This study aimed to generate targeted data in a laboratory model species (Xenopus laevis) using a model DIO inhibitor, iopanoic acid (IOP), to characterize linkages between in vitro potency, in vivo biochemical responses, and adverse organismal outcomes. In vitro potency of IOP toward DIOs was evaluated using previously developed in vitro screening assays, which showed concentration-dependent inhibition of human DIO1 (IC50: 97 µM) and DIO2 (IC50: 231 µM) but did not inhibit human or X. laevis DIO3 under the assay conditions. In vivo exposure of larval X. laevis to 0, 2.6, 5.3, and 10.5 µM IOP caused thyroid-related biochemical profiles in the thyroid gland and plasma consistent with hyperthyroxinemia but resulted in delayed metamorphosis and significantly reduced growth in the highest 2 exposure concentrations. Independent evaluations of dio gene expression ontogeny, together with existing literature, supported interpretation of IOP-mediated effects resulting in a proposed adverse outcome pathway for DIO2 inhibition leading to altered amphibian metamorphosis. This study highlights the types of mechanistic data needed to move toward predicting in vivo outcomes of regulatory concern from in vitro bioactivity data.
Becker,
The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating development in Rana catesbeiana tadpoles.
1997, Pubmed
Becker,
The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating development in Rana catesbeiana tadpoles.
1997,
Pubmed
Boorse,
Expression and hypophysiotropic actions of corticotropin-releasing factor in Xenopus laevis.
2004,
Pubmed
,
Xenbase
Braga,
Clinical review 129: Oral cholecystographic agents and the thyroid.
2001,
Pubmed
Brown,
The role of deiodinases in amphibian metamorphosis.
2005,
Pubmed
,
Xenbase
Cai,
Expression of type II iodothyronine deiodinase marks the time that a tissue responds to thyroid hormone-induced metamorphosis in Xenopus laevis.
2004,
Pubmed
,
Xenbase
Citterio,
De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone.
2017,
Pubmed
Committee on Human and Environmental Exposure Science in the 21st Century,
2012,
Pubmed
Denver,
Acceleration of anuran amphibian metamorphosis by corticotropin-releasing hormone-like peptides.
1993,
Pubmed
Eng,
Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
1999,
Pubmed
Galton,
The ontogeny of iodothyronine 5'-monodeiodinase activity in Rana catesbeiana tadpoles.
1988,
Pubmed
Galton,
The role of 3,5,3'-triiodothyronine in the physiological action of thyroxine in the premetamorphic tadpole.
1989,
Pubmed
Haselman,
Targeted Pathway-based In Vivo Testing Using Thyroperoxidase Inhibition to Evaluate Plasma Thyroxine as a Surrogate Metric of Metamorphic Success in Model Amphibian Xenopus laevis.
2020,
Pubmed
,
Xenbase
Hassan,
Neurodevelopment and Thyroid Hormone Synthesis Inhibition in the Rat: Quantitative Understanding Within the Adverse Outcome Pathway Framework.
2017,
Pubmed
Hornung,
Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.
2018,
Pubmed
Huang,
Metamorphosis is inhibited in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase.
1999,
Pubmed
,
Xenbase
Huang,
Timing of metamorphosis and the onset of the negative feedback loop between the thyroid gland and the pituitary is controlled by type II iodothyronine deiodinase in Xenopus laevis.
2001,
Pubmed
,
Xenbase
Kuiper,
Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil.
2006,
Pubmed
,
Xenbase
Larsen,
Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.
1979,
Pubmed
Marsh-Armstrong,
Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase.
1999,
Pubmed
,
Xenbase
Mayasich,
Xenopus laevis and human type 3 iodothyronine deiodinase enzyme cross-species sensitivity to inhibition by ToxCast chemicals.
2021,
Pubmed
,
Xenbase
Noyes,
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.
2019,
Pubmed
Obregon,
Evidence against a major role of L-thyroxine at the pituitary level: studies in rats treated with iopanoic acid (telepaque).
1980,
Pubmed
Olker,
Evaluating Iodide Recycling Inhibition as a Novel Molecular Initiating Event for Thyroid Axis Disruption in Amphibians.
2018,
Pubmed
,
Xenbase
Olker,
Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.
2019,
Pubmed
Paul Friedman,
Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.
2016,
Pubmed
Paul-Friedman,
Limited Chemical Structural Diversity Found to Modulate Thyroid Hormone Receptor in the Tox21 Chemical Library.
2019,
Pubmed
Renko,
Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay.
2012,
Pubmed
Renko,
An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases.
2015,
Pubmed
Ritz,
Dose-Response Analysis Using R.
2015,
Pubmed
Schreiber,
Remodeling of the intestine during metamorphosis of Xenopus laevis.
2005,
Pubmed
,
Xenbase
Shintani,
Tissue-specific regulation of type III iodothyronine 5-deiodinase gene expression mediates the effects of prolactin and growth hormone in Xenopus metamorphosis.
2002,
Pubmed
,
Xenbase
Sternberg,
Control of pituitary thyroid-stimulating hormone synthesis and secretion by thyroid hormones during Xenopus metamorphosis.
2011,
Pubmed
,
Xenbase
Thomas,
The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.
2019,
Pubmed
Tietge,
Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole.
2013,
Pubmed
,
Xenbase
Wang,
Thyroid hormone-induced gene expression program for amphibian tail resorption.
1993,
Pubmed
,
Xenbase
Wang,
High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library.
2018,
Pubmed
Wang,
High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition.
2019,
Pubmed
Wang,
Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition.
2021,
Pubmed
